Bay98-7196, Dose Finding / POC Study (Q65353449)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bay98-7196, Dose Finding / POC Study |
clinical trial |
Statements
A Randomized, Double-blind, Double-dummy, Parallel- Group, Multi-center Phase IIb Study to Assess the Efficacy and Safety of Different Dose Combinations of an Aromatase Inhibitor and a Progestin in an Intravaginal Ring Versus Placebo and Leuprorelin / Leuprolide Acetate in Women With Symptomatic Endometriosis Over a 12-week Treatment Period (English)
0 references
16 October 2014
0 references
24 October 2016
0 references
319
0 references